Prognostic value of pathologic complete response after primary chemotherapy in patients with hormone receptor-positive breast cancer.
Abstract
Data di Pubblicazione:
2005
Citazione:
Prognostic value of pathologic complete response after primary chemotherapy in patients with hormone receptor-positive breast cancer / Guarneri, Valentina; K., Broglio; S., Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; Am Gonzalez, Angulo. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - STAMPA. - 94, s1:(2005), pp. s127-s128. ( 28th San Antonio Breast Cancer Symposium San Antonio, TX December 8-12, 2005).
Abstract:
The achievement of a pathologic complete response (pCR) in breast cancer patients treated with primary chemotherapy is the most reliable predictor of survival. Patients with hormone receptor (HR) positive tumors hare less likely to achieve a pCR; however, the prognostic role of pCR in these patients is not well characterized. In this study including 1731 patients, we have demonstrated that the achievement of pCR is associated with better outcome regardless of HR status.
Tipologia CRIS:
Abstract in Rivista
Keywords:
pathologic complete response; hormone receptor; chemotherapy; neoadjuvant therapy; breast cancer
Elenco autori:
Guarneri, Valentina; K., Broglio; S., Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; Am Gonzalez, Angulo
Link alla scheda completa:
Titolo del libro:
Breast Cancer Research and Treatmeny, Special Issue: 28th San Antonio Breast Cancer Symposium 2005
Pubblicato in: